The role of lactose carrier on the powder behavior and aerodynamic performance of bosentan microparticles for dry powder inhalation

Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance

10.1016/j.ijpharm.2015.06.044 ◽

2015 ◽

Vol 491 (1-2) ◽

pp. 231-242 ◽

Cited By ~ 22

Author(s):

Eva Faulhammer ◽

Verena Wahl ◽

Sarah Zellnitz ◽

Johannes G. Khinast ◽

Amrit Paudel

Keyword(s):

Aerodynamic Performance ◽

Dry Powder Inhalation ◽

A New Role of Fine Excipient Materials in Carrier-Based Dry Powder Inhalation Mixtures: Effect on Deagglomeration of Drug Particles During Mixing Revealed

AAPS PharmSciTech ◽

10.1208/s12249-017-0767-4 ◽

2017 ◽

Vol 18 (8) ◽

pp. 2862-2870 ◽

Cited By ~ 8

Author(s):

Ahmed O. Shalash ◽

Mustafa M. A. Elsayed

Keyword(s):

Dry Powder Inhalation ◽

Influence of Flow Rate and Usage in Drastic Condition on the Aerodynamic Performance of a Formoterol Dry Powder Formulation Using Different Kinds of Capsules

10.26226/morressier.57d6b2b6d462b8028d88d6ce ◽

2016 ◽

Author(s):

Nathalie Wauthoz

Keyword(s):

Flow Rate ◽

Aerodynamic Performance ◽

Dry Powder ◽

Powder Formulation ◽

Drastic Condition

Decision letter for "Fluidization of fine lactose for dry powder inhalation: A comparison of assisting methods"

10.1002/cjce.24002/v2/decision1 ◽

2020 ◽

Keyword(s):

Dry Powder Inhalation ◽

Review for "Fluidization of fine lactose for dry powder inhalation: A comparison of assisting methods"

10.1002/cjce.24002/v1/review3 ◽

2020 ◽

Author(s):

MingYan Liu

Keyword(s):

Dry Powder Inhalation ◽

INSPIRE: A Phase 3 Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of LIQ861 in PULMONARY ARTERIAL HYPERTENSION (PAH) (Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil NCT03399604)

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7402 ◽

2019 ◽

Author(s):

N.S. Hill ◽

J.P. Feldman ◽

S. Sahay ◽

D.J. Levine ◽

R.F. Roscigno ◽

...

Keyword(s):

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Multicenter Study ◽

Dry Powder Inhalation ◽

Dry Powder ◽

Open Label ◽

Phase 3 ◽

Pulmonary Arterial

Optimized particle engineering of fluticasone propionate and salmeterol xinafoate by spray drying technique for dry powder inhalation

Advanced Powder Technology ◽

10.1016/j.apt.2016.10.022 ◽

2017 ◽

Vol 28 (2) ◽

pp. 534-542 ◽

Cited By ~ 5

Author(s):

Faezeh Khandouzi ◽

Zahra Daman ◽

Kambiz Gilani

Keyword(s):

Fluticasone Propionate ◽

Spray Drying ◽

Particle Engineering ◽

Dry Powder Inhalation ◽

Dry Powder ◽

Salmeterol Xinafoate

The effect of the inhalation flow on the performance of a dry powder inhalation system

10.1016/0378-5173(92)90012-q ◽

1992 ◽

Vol 81 (2-3) ◽

pp. 199-203 ◽

Cited By ~ 30

Author(s):

P. Zanen ◽

P.I. van Spiegel ◽

H. van der Kolk ◽

E. Tushuizen ◽

R. Enthoven

Keyword(s):

Dry Powder Inhalation ◽

“Pierce and inhale” design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs

10.1016/j.ijpharm.2015.04.003 ◽

2015 ◽

Vol 487 (1-2) ◽

pp. 197-204 ◽

Cited By ~ 24

Author(s):

Francesco Martinelli ◽

Anna Giulia Balducci ◽

Alessandra Rossi ◽

Fabio Sonvico ◽

Paolo Colombo ◽

...

Keyword(s):

Aerodynamic Performance ◽

Dry Powder Inhalers ◽

Investigation on the aerosol performance of dry powder inhalation hypromellose capsules with different lubricant levels

10.1016/j.ijpharm.2015.07.034 ◽

2015 ◽

Vol 492 (1-2) ◽

pp. 258-263 ◽

Cited By ~ 7

Author(s):

I.Y. Saleem ◽

F. Diez ◽

B.E. Jones ◽

N. Kayali ◽

L. Polo

Keyword(s):

Dry Powder Inhalation ◽

Dry Powder ◽

Aerosol Performance